$ACT News Corner drug

New Post Public Reply Private Reply Replies (0) Message Board

May 6, 2014 at 11:36 AM

$ACT News

Corner drug store may move overseas to save on taxes
6:30 a.m. April 16, 2014
- Al Lewis

Intuitive Surgical slumps; Facebook extends rally
3:41 p.m. April 9, 2014
- Saumya Vaishampayan

Actavis acquires Silom Medical for $100 million
10:19 a.m. April 1, 2014
- MarketWatch.com

The 10 most overbought stocks in the S&P 500 index
12:19 p.m. March 25, 2014
- The Trading Deck

UK drug rejection, patent concerns take a bite out of Celgene shares

1:33 p.m. March 14, 2014
- blogs.marketwatch.com

Mylan to start selling generic Celebrex in May
7:22 a.m. March 13, 2014
- MarketWatch.com

Pfizer loses Celebrex patent ruling; shares halted but effect muted

3:21 p.m. March 12, 2014
- blogs.marketwatch.com

Staples awash in red; eBay up as Icahn posts new letter
4:09 p.m. March 6, 2014
- Victor Reklaitis

Icahn Enterprises reports profit up 144% in 2013
10:22 a.m. March 3, 2014
- MarketWatch

Citadel hedge fund’s recent moves
11:12 a.m. Feb. 25, 2014
- Insider Monkey

Stocks rally; S&P 500 ends right below record
4:45 p.m. Feb. 24, 2014
- Victor Reklaitis

U.S. stock market is starting to ride a tech M&A wave
5:31 a.m. Feb. 24, 2014
- Wallace Witkowski

Actavis continues hot streak with better-than-expected earnings

11:21 a.m. Feb. 20, 2014
- blogs.marketwatch.com

Actavis swings to loss on charges, write-downs
8:03 a.m. Feb. 20, 2014
- MarketWatch.com

Pharma megamergers bring higher profits, better returns, study says

1:59 p.m. Feb. 19, 2014
- blogs.marketwatch.com

Actavis, Forest shares continue their climb in aftermath of $25 billion deal

11:03 a.m. Feb. 19, 2014
- blogs.marketwatch.com

U.S. stocks edge up; Nasdaq gains for 8th day in a row
4:38 p.m. Feb. 18, 2014
- Anora Mahmudova

Forest Laboratories, Actavis surge on buyout deal
4:10 p.m. Feb. 18, 2014
- Ben Eisen

S&P 500, Nasdaq extend win streaks but Dow dips: stock market live blog recap

4:06 p.m. Feb. 18, 2014
- blogs.marketwatch.com

Forest buyout may not spell the end of dealmaking for Actavis

3:00 p.m. Feb. 18, 2014
- blogs.marketwatch.com

10-Q: ACTAVIS PLC
5:15 p.m. May 5, 2014
- Edgar Online - (EDG = 10Q, 10K)

Hottest Healthcare Stocks Now – HMSY ACAD ACT MWIV

1:45 p.m. May 5, 2014
- InvestorPlace.com

Best Five Stocks Over $100
10:07 a.m. May 3, 2014
- 247WallSt.com

AstraZeneca Nixes New Bid As Pfizer Woos British PM

1:11 p.m. May 2, 2014
- Investors Business Daily

Earnings Beat at Endo, Shares Up on Improved Outlook - Analyst Blog

12:10 p.m. May 2, 2014
- Zacks.com

Tyco Eyes 'Business Friendly' Ireland

8:35 a.m. May 2, 2014
- The Wall Street Journal Interactive Edition

What's With All The Healthcare And Pharmaceutical Mergers?

5:25 p.m. May 1, 2014
- TheStreet.com

Avanir Wins Lawsuit, Shares Up - Analyst Blog

4:39 p.m. May 1, 2014
- Zacks.com

A Look At World Stocks' Q1: Shire, Actavis, NXP Semi

4:32 p.m. May 1, 2014
- Investors Business Daily

Mylan Beats on Earnings, Misses on Sales - Analyst Blog

1:17 p.m. May 1, 2014
- Zacks.com

Company News for May 01, 2014 - Corporate Summary

10:06 a.m. May 1, 2014
- Zacks.com

Actavis plc (ACT): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report

8:00 a.m. May 1, 2014
- Zacks.com

Actavis PLC (ACT): Today's Featured Health Care Winner

5:00 p.m. April 30, 2014
- TheStreet.com

Actavis Beats Q1 Views, Looks To Supersized Future

4:28 p.m. April 30, 2014
- Investors Business Daily

Actavis Tops Q1 Earnings & Sales Estimates - Analyst Blog

4:25 p.m. April 30, 2014
- Zacks.com

Avanir up on patent case decision

2:55 p.m. April 30, 2014
- Seeking Alpha

Actavis Management Discusses Q1 2014 Results - Earnings Call Transcript

2:20 p.m. April 30, 2014
- Seeking Alpha

Actavis Q1 Earnings Beat On Generic Cymbalta Surprise

10:10 a.m. April 30, 2014
- Investors Business Daily

Zacks Rank #1 Additions for Wednesday - Tale of the Tape

9:30 a.m. April 30, 2014
- Zacks.com

Biggest Movers in Healthcare Stocks Now – ACT HSP FRX AZN

8:30 a.m. April 30, 2014
- InvestorPlace.com

Financial Results, Study Results, and Conference Schedules - Analyst Notes on Actavis, BMS, Baxter, Biogen Idec and AbbVie
9:00 a.m. Today9:00 a.m. May 6, 2014
- PR Newswire - PRF

Actavis and Forest Announce Effectiveness of Registration Statement
on Form S-4
9:02 a.m. May 5, 2014
- BusinessWire - BZX

Actavis and Forest Announce Effectiveness of Registration Statement on Form S-4
9:00 a.m. May 5, 2014
- PR Newswire - PRF

Pfizer Expects $100 Billion Grab for AstraZeneca to Boost Pipeline
and Drop Tax Rate, an Industrial Info News Alert
6:31 a.m. April 30, 2014
- Marketwire

Stocks Close to Reporting their Earnings -- Research on Actavis, NYSE Community Bancorp, Hess, and Dominion Resources
4:36 a.m. April 30, 2014
- PR Newswire - PRF

Actavis Sues FDA Regarding Delay of Generic Celebrex® Approval
5:14 p.m. April 28, 2014
- PR Newswire - PRF

Strategic Collaborations, Fresh Agreements, and Upcoming Conferences - Analyst Notes on Biogen, Bristol-Myers, AbbVie, Actavis and Bard
8:00 a.m. April 28, 2014
- PR Newswire - PRF

Stockholder Rights Plan, Quarterly Results, Clinical Trial Results, Purchase Agreements, and New Contracts - Analyst Notes on Allergan, Gilead, Pfizer, Actavis and Express Scripts
8:00 a.m. April 25, 2014
- PR Newswire - PRF

Actavis Announces Celebrex® Patent Challenge Settlement
9:20 a.m. April 24, 2014
- PR Newswire - PRF

Actavis Announces Departure of G. Frederick Wilkinson, President, Actavis Global R&D
9:03 a.m. April 21, 2014
- PR Newswire - PRF

Actavis to Acquire Four Products from Akorn
4:15 p.m. April 17, 2014
- PR Newswire - PRF

Actavis and Forest Laboratories Receive FTC Second Request Under
Hart-Scott-Rodino
4:05 p.m. April 17, 2014
- BusinessWire - BZX

Actavis and Forest Laboratories Receive FTC Second Request Under Hart-Scott-Rodino
4:05 p.m. April 17, 2014
- PR Newswire - PRF

Actavis Announces Agreement Related to Generess® FE Patent Challenge Litigation
8:00 a.m. April 15, 2014
- PR Newswire - PRF

Recent Acquisitions, Trial Opinions, Upcoming Earnings, Inducement Grants, and Clinical Trial Results - Analyst Notes on Actavis, The Medicines Company, Hospira, Horizon Pharma, and Galectin
8:00 a.m. April 11, 2014
- PR Newswire - PRF

Pharma Equities under Review -- Research on Mylan, Actavis, Hospira, and Medicines
12:30 p.m. April 10, 2014
- PR Newswire - PRF

Actavis Launches Asia Pacific Regional Headquarters in Singapore
8:00 p.m. April 2, 2014
- PR Newswire - PRF

Particle Sciences and Actavis Enter into Joint Development Agreement
11:00 a.m. April 1, 2014
- PR Newswire - PRF

Actavis Acquires Silom Medical Company
8:30 a.m. April 1, 2014
- PR Newswire - PRF

Actavis Completes Divestiture of Commercial Operations in Seven Western European Countries to Aurobindo Pharma Limited
8:00 a.m. April 1, 2014
- PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

SMPL Faces Legal Drama: What Investors Need to Know

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

D-Wave Faces Legal Questions After CFO Exit and Losses

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

USPS Honors 150 Years of the U.S. Coast Guard Academy

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

U.S. Green Beret's Mission: Clearing Landmines in Ukraine

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

Damp or Dry: The Battle for Healthy Air in Colorado

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Ajman Spotlights Tourism at Arabian Travel Market 2026

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Pizza: The Unlikely Symbol of Universal Togetherness

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...